The Telangana health authorities have issued an urgent public safety alert after detecting toxic adulteration in a children’s medicinal syrup. The Drugs Control Administration (DCA) of Telangana ordered an immediate “stop use” of a specific batch of the syrup after laboratory analysis confirmed the presence of ethylene glycol, a hazardous industrial chemical that is strictly prohibited in pharmaceutical formulations.

The action follows a national-level alert from drug regulators, prompting swift intervention by state authorities to prevent any risk to children’s health. Officials have directed that the affected syrup batch must not be consumed, sold, or distributed under any circumstances until further instructions are issued.

The syrup, commonly prescribed for children to manage allergies, respiratory discomfort, and related symptoms, is widely used in paediatric care. Its contamination with ethylene glycol has raised serious concerns, as the chemical is known for its high toxicity and potential to cause severe health complications, especially in infants and young children.

According to the DCA, all drug inspectors across Telangana have been instructed to immediately identify and seize stocks of the affected batch from medical shops, hospitals, wholesalers, and distributors. The product must be quarantined and kept away from circulation to ensure public safety. Pharmacists and healthcare institutions have been directed to cooperate fully with the inspection teams and report any availability of the syrup.

Parents and caregivers have been advised to check any children’s syrup in their homes carefully. If the affected batch is found, its use must be stopped immediately, and the nearest drug control authority should be informed. The government has also activated a toll-free helpline to enable citizens to report suspected stock quickly and receive guidance.

What is Ethylene Glycol and Why Is It Dangerous?

Ethylene glycol is a colourless, odourless, and sweet-tasting chemical primarily used in industrial applications such as antifreeze, coolants, and solvents. It has no medical or therapeutic use in pharmaceutical products.

When ingested, ethylene glycol is rapidly absorbed into the bloodstream and metabolised into toxic compounds that can severely damage vital organs. Initial symptoms may appear mild and include:

• Nausea and vomiting
• Dizziness and confusion
• Drowsiness or unusual behaviour

As poisoning progresses, it can lead to:

• Severe metabolic acidosis
• Kidney failure
• Respiratory distress
• Nervous system damage
• Coma and death in extreme cases

Children are particularly vulnerable due to their lower body weight and developing organs, making even small quantities potentially fatal if not treated promptly.

Increased Vigilance After Previous Incidents

This latest alert comes amid heightened national concern over the safety of paediatric syrups following earlier incidents of contamination that resulted in serious illness and child fatalities in different parts of the country. Regulators have intensified quality checks on cough syrups and other liquid medicines, which are more prone to contamination if manufacturing standards are compromised.

Authorities have reiterated that pharmaceutical companies must strictly adhere to Good Manufacturing Practices (GMP) and ensure that all raw materials used in drug production are pharmaceutical-grade and properly tested.

Regulatory Action and Investigation

The Telangana Drugs Control Administration has initiated a detailed investigation into how the toxic chemical entered the syrup. Samples have been sent for further testing, and regulatory action against the manufacturer will be taken based on the outcome. Penalties may include suspension of licenses, product recalls, and legal proceedings under drug safety laws.

Officials have emphasized that public health and child safety remain the highest priorities and that zero tolerance will be shown toward any lapse in drug manufacturing standards.

Advisory to Parents and Healthcare Professionals

• Do not use the affected syrup if it is in your possession.
• Check the batch number on medicine bottles before administering any paediatric syrup.
• Report suspected stock immediately to local drug authorities.
• Consult a qualified doctor for alternative medications if the syrup has been prescribed.
• Seek immediate medical help if a child shows unusual symptoms after consuming any medicine.

The Telangana government’s swift response reflects a strong commitment to safeguarding children’s health and maintaining strict oversight over pharmaceutical products. The incident also serves as a reminder of the importance of rigorous drug quality control and the need for constant vigilance in protecting public health.